- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07580183
Spatial Scene Recognition Memory in Epilepsy Surgery
Investigations of Spatial Recognition Memory to Improve Cognitive Outcomes in Epilepsy Surgery
Přehled studie
Postavení
Podmínky
Detailní popis
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Nigel P Pedersen, MD
- Telefonní číslo: 916-734-3251
- E-mail: nppedersen@health.ucdavis.edu
Studijní místa
-
-
California
-
Sacramento, California, Spojené státy, 95817
- Nábor
- UC Davis Medical Center
-
Kontakt:
- Nigel P Pedersen, MD
- Telefonní číslo: 916-734-3251
- E-mail: nppedersen@health.ucdavis.edu
-
-
Georgia
-
Atlanta, Georgia, Spojené státy, 30322
- Nábor
- Emory University Hospital
-
Kontakt:
- Daniel L Drane, PhD
- Telefonní číslo: 404-727-2844
- E-mail: ddrane@emory.edu
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Age 18 years or older
- For Aims I and III: Diagnosis of focal epilepsy or temporal lobe lesion; patients undergoing evaluation for or having undergone epilepsy surgery
- For Aim II: Healthy adult participants
- Full-Scale IQ ≥ 70
- English proficiency sufficient to understand and complete the task
- For Aim I: Enrolled in or eligible for Emory University epilepsy surgery research registry
- For Aim III: Undergoing clinically indicated stereoelectroencephalography (SEEG) at UC Davis Medical Center
- Able to provide informed consent (or for Aim I retrospective component, prior consent in Emory registry)
Exclusion Criteria:
- Full-Scale IQ < 70
- Inability to provide informed consent
- For Aim III: Age > 55 years
- For Aim II: History of neurological or psychiatric disorder (as applicable per study protocol)
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Základní věda
- Přidělení: Nerandomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Aim I: Lesion-Symptom Mapping
Patients with temporal lobe lesions (n≈310) and healthy controls (n≈150) at Emory University. Retrospective cohort with existing surgical lesions plus prospectively enrolled new surgical patients (~60 over 5 years). Intervention(s): Behavioral: Virtual Tour Recognition Memory Task; Diagnostic: MRI neuroimaging and neuropsychological assessment |
Participants are passively navigated through virtual tour scenes (5-second video clips) during a study phase and are asked to generate descriptive names for each scene.
During the test phase, they view novel, spatially similar (same configuration, different objects), or identical scenes and rate familiarity, indicate old/new judgments, report déjà vu sensations, and attempt to recall scene names.
The task consists of two study-test blocks.
This is a cognitive/behavioral assessment, not a therapeutic intervention.
Pre- and post-surgical structural MRI (T1-weighted, diffusion-weighted imaging, resting-state fMRI) obtained as part of the clinical epilepsy surgery evaluation at Emory University.
Extensive neuropsychological battery administered pre- and post-operatively (6 months and 1 year) including Wechsler memory scales, Rey-Osterrieth Complex Figure, confrontation naming, and additional measures.
|
|
Experimentální: Aim II: Scalp ERP Study
Healthy participants (n=80) recruited from UC Davis campus community.
Intervention: Behavioral: Virtual Tour Recognition Memory Task (still-image version) during Scalp EEG/ERP recording and eye tracking
|
Participants are passively navigated through virtual tour scenes (5-second video clips) during a study phase and are asked to generate descriptive names for each scene.
During the test phase, they view novel, spatially similar (same configuration, different objects), or identical scenes and rate familiarity, indicate old/new judgments, report déjà vu sensations, and attempt to recall scene names.
The task consists of two study-test blocks.
This is a cognitive/behavioral assessment, not a therapeutic intervention.
|
|
Experimentální: Aim III: Intracranial EEG
Patients with epilepsy undergoing clinically indicated SEEG (n≈80) at UC Davis Medical Center. Behavioral Intervention: Virtual Tour Recognition Memory Task; Other Intervention: Intracranial EEG recording via clinically placed electrodes, a minority of which have research microelectrodes (FDA-approved Dixi micro-macro or Behnke-Fried Ad-Tech electrodes) |
Participants are passively navigated through virtual tour scenes (5-second video clips) during a study phase and are asked to generate descriptive names for each scene.
During the test phase, they view novel, spatially similar (same configuration, different objects), or identical scenes and rate familiarity, indicate old/new judgments, report déjà vu sensations, and attempt to recall scene names.
The task consists of two study-test blocks.
This is a cognitive/behavioral assessment, not a therapeutic intervention.
Patients undergoing clinically indicated stereoelectroencephalography (SEEG) for seizure localization have electrodes implanted at locations determined solely by clinical need.
In a subset of patients, FDA-approved research electrodes (Dixi micro-macro electrodes or Behnke-Fried As-Tech electrodes with tetrode components) substitute standard clinical electrodes at the same clinically determined locations.
These electrodes have the same geometry as clinical electrodes and are FDA-approved.
The tetrode component enables single-neuron recording for research purposes and adds no additional risk.
Electrode placement is not altered by study participation.
Local field potentials (LFP) and, where available, single-unit data are recorded during the virtual tour task and resting state.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Scene familiarity discrimination accuracy
Časové okno: From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
|
Rate of correct familiarity judgments for spatially similar test scenes versus novel scenes (recognition without identification/RWI effect), measured as the proportion of "familiar" responses to configurally matched scenes minus false alarm rate to novel scenes.
|
From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
|
|
Scene recall accuracy
Časové okno: From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
|
Proportion of test scenes for which participants correctly recall the name or identifying details of the corresponding study scene (verified recall), separately for identical repeat scenes and configurally similar scenes.
|
From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
|
|
Lesion-symptom correlation for familiarity and recall (Aim I)
Časové okno: Testing is scheduled within eight weeks of enrollment for all patients, with repeat testing at six and 12 months after surgery for those enrolled pre-operatively
|
Voxel-based lesion-symptom mapping (VBLSM) correlating surgical lesion volumes in temporal lobe subregions (temporopolar, perirhinal, entorhinal, parahippocampal, hippocampal) with familiarity and recall behavioral scores.
|
Testing is scheduled within eight weeks of enrollment for all patients, with repeat testing at six and 12 months after surgery for those enrolled pre-operatively
|
|
ERP amplitude and latency associated with familiarity and recall (Aim II)
Časové okno: During EEG recording session
|
Amplitude and latency of event-related potential components (FN400, late positive component) in specified scalp regions (e.g., LAS, RAS, LPS, RPS) as a function of scene familiarity and recall conditions.
|
During EEG recording session
|
|
Intracranial theta and gamma power and connectivity during familiarity judgments (Aim III)
Časové okno: During intracranial EEG monitoring (typically 1-2 weeks hospital stay)
|
Theta (3-7 Hz) and gamma-band (30-150 Hz) event-related synchronization/desynchronization in parahippocampal, perirhinal, entorhinal, and hippocampal contacts during familiarity versus recall conditions, plus functional connectivity measures (imaginary coherence, phase-amplitude coupling).
|
During intracranial EEG monitoring (typically 1-2 weeks hospital stay)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Déjà vu report rate
Časové okno: During testing sessions with the virtual tour
|
Proportion of test trials in which participants report a feeling of déjà vu, analyzed by scene condition (similar, repeat, novel).
|
During testing sessions with the virtual tour
|
|
Vividness of Visual Imagery Questionnaire, Second Edition (VVIQ-2) scores (Aim I)
Časové okno: During testing session
|
Self-reported vividness of visual imagery correlated with lesion location and recognition memory performance.
The VVIQ-2 is a 32-item self-report questionnaire in which each item is rated on a scale from 1 (no image at all) to 5 (perfectly clear and vivid).
Total scores range from 32 to 160.
Higher scores indicate more vivid visual imagery.
|
During testing session
|
|
Hyperfamiliarity commission errors
Časové okno: During testing session
|
Rate of false positive familiarity judgments for novel scenes (false alarms), as a measure of hyperfamiliarity.
|
During testing session
|
|
Neuropsychological test performance (Aim I)
Časové okno: Pre-surgery and 6 months / 1 year post-surgery
|
Standard neuropsychological battery scores (Wechsler Memory Scale, Rey-Osterrieth Complex Figure, confrontation naming, etc.) correlated with virtual tour performance and lesion characteristics.
|
Pre-surgery and 6 months / 1 year post-surgery
|
|
Single-unit firing rate (subset of patients in Aim III)
Časové okno: During intracranial EEG monitoring
|
Mean firing rate (spikes per second) of individual neurons recorded from parahippocampal and perirhinal cortex during familiarity versus recall conditions, in patients with tetrode/microelectrode recordings.
|
During intracranial EEG monitoring
|
|
Single-unit stimulus selectivity (subset of patients in Aim III)
Časové okno: During intracranial EEG monitoring
|
Selectivity index (area under the receiver operating characteristic curve) quantifying the discriminability of familiar versus novel scene conditions in individual neurons recorded from parahippocampal and perirhinal cortex, in patients with tetrode/microelectrode recordings.
|
During intracranial EEG monitoring
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Publikace a užitečné odkazy
Užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
- neuropsychologie
- potenciály související s událostmi
- vědomí
- hippocampus
- SEEG
- operace epilepsie
- prostorová paměť
- obeznámenost
- intrakraniální EEG
- stereo-elektroencefalografie
- recognition memory
- recollection
- neural circuits of memory
- phenomenology of memory
- scene memory
- virtual tour
- lesion-symptom mapping
- network-symptom mapping
- cognitive electrophysiology
- iEEG
- parahippocampal gyrus
- perirhinal cortex
- tetrodes
- deja vu
Další relevantní podmínky MeSH
- Epileptické syndromy
- Neurologické projevy
- Onemocnění mozku
- Onemocnění centrálního nervového systému
- Nemoci nervového systému
- Neurobehaviorální projevy
- Epilepsie
- Patologické stavy, příznaky a symptomy
- Chování
- Příznaky a symptomy
- Prostorové chování
- Drogově rezistentní epilepsie
- Poruchy paměti
- Částečná epilepsie
- Epilepsie, temporální lalok
- Orientace, Prostorová
Další identifikační čísla studie
- 2347891
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Časový rámec sdílení IPD
Kritéria přístupu pro sdílení IPD
Typ podpůrných informací pro sdílení IPD
- PROTOKOL STUDY
- MÍZA
- ICF
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .